학술논문
Treatment of high‐risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes.
Document Type
Article
Author
Source
Pediatric Blood & Cancer; Feb2024, Vol. 71 Issue 2, p1-9, 9p
Subject
Language
ISSN
15455009